Literature DB >> 12813010

Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.

Niall P Hyland1, Frida Sjöberg, Iain R Tough, Herbert Herzog, Helen M Cox.   

Abstract

1 Neuropeptide Y (NPY), peptide YY (PYY) and pancreatic polypeptide (PP) differentially activate three Y receptors (Y(1), Y(2) and Y(4)) in mouse and human isolated colon. 2 The aim of this study was to characterise Y(2) receptor-mediated responses in colon mucosa and longitudinal smooth muscle preparations from wild type (Y(2)+/+) and knockout (Y(2)-/-) mice and to compare the former with human mucosal Y agonist responses. Inhibition of mucosal short-circuit current and increases in muscle tone were monitored in colonic tissues from Y(2)+/+ and Y(2)-/- mice+/-Y(1) ((R)-N-[[4-(aminocarbonylaminomethyl)phenyl)methyl]-N(2)-(diphenylacetyl)-argininamide-trifluoroacetate (BIBO3304) or Y(2) (S)-N(2)-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6H)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]-argininamide (BIIE0246) antagonists. 3 Predictably, Y(2)-/- tissues were insensitive to Y(2)-preferred agonist PYY(3-36) (</=100 nM), but unexpectedly Y(4)-preferred PP responses were right-shifted probably as a consequence of elevated circulating PP levels, particularly in male Y(2)-/- mice (Sainsbury et al., 2002). 4 BIBO3304 and BIIE0246 elevated mucosal ion transport, indicating blockade of inhibitory mucosal tone in Y(2)+/+ tissue. While BIBO3304 effects were unchanged, those to BIIE0246 were absent in Y(2)-/- mucosae. Neither antagonist altered muscle tone; however, BIIE0246 blocked NPY and PYY(3-36) increases in Y(2)+/+ basal tone. BIBO3304 abolished residual Y(1)-mediated NPY responses in Y(2)-/- smooth muscle. 5 Tetrodotoxin significantly reduced BIIE0246 and PYY(3-36) effects in Y(2)+/+ mouse and human mucosae, but had no effect upon Y-agonist contractile responses, indicating that Y(2) receptors are located on submucosal, but not myenteric neurones. 6 Tonic activation of submucosal Y(2) receptors by endogenous NPY, PYY or PYY(3-36) could indirectly reduce mucosal ion transport in murine and human colon, while direct activation of Y(2) receptors on longitudinal muscle results in contraction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813010      PMCID: PMC1573894          DOI: 10.1038/sj.bjp.0705298

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

Review 1.  Peptidergic regulation of intestinal ion transport. A major role for neuropeptide Y and the pancreatic polypeptides.

Authors:  H M Cox
Journal:  Digestion       Date:  1998 Jul-Aug       Impact factor: 3.216

2.  Distribution of enteroglucagon- and peptide YY-immunoreactive cells in the intestinal mucosa of germ-free and conventional mice.

Authors:  R M Arantes; A M Nogueira
Journal:  Cell Tissue Res       Date:  1997-10       Impact factor: 5.249

Review 3.  XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.

Authors:  M C Michel; A Beck-Sickinger; H Cox; H N Doods; H Herzog; D Larhammar; R Quirion; T Schwartz; T Westfall
Journal:  Pharmacol Rev       Date:  1998-03       Impact factor: 25.468

4.  Selective inhibition of neuropeptide Y Y1 receptors by BIBP3226 in rat and human epithelial preparations.

Authors:  I R Tough; H M Cox
Journal:  Eur J Pharmacol       Date:  1996-08-22       Impact factor: 4.432

5.  The effects of neuropeptide Y and its fragments upon basal and electrically stimulated ion secretion in rat jejunum mucosa.

Authors:  H M Cox; A W Cuthbert
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

6.  Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue.

Authors:  P Gregor; Y Feng; L B DeCarr; L J Cornfield; M L McCaleb
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

7.  Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed.

Authors:  M A McAuley; T C Westfall
Journal:  J Pharmacol Exp Ther       Date:  1992-06       Impact factor: 4.030

8.  Y2-receptor-mediated selective inhibition of slow, inhibitory postsynaptic potential in submucous neurones of guinea-pig caecum.

Authors:  S M Cunningham; S Mihara; G M Lees
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

9.  Chemical coding of neurons in the myenteric plexus and external muscle of the small and large intestine of the mouse.

Authors:  Q Sang; H M Young
Journal:  Cell Tissue Res       Date:  1996-04       Impact factor: 5.249

10.  Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.

Authors:  M Goumain; T Voisin; A M Lorinet; M Laburthe
Journal:  Biochem Biophys Res Commun       Date:  1998-06-09       Impact factor: 3.575

View more
  20 in total

1.  Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa.

Authors:  S Joshi; I R Tough; H M Cox
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  The gut as a sensory organ.

Authors:  John B Furness; Leni R Rivera; Hyun-Jung Cho; David M Bravo; Brid Callaghan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

Review 3.  Neuropeptides and their receptors: innovative science providing novel therapeutic targets.

Authors:  Susan D Brain; Helen M Cox
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.

Authors:  Duc Quyen Chu; Helen M Cox; Soraia K P Costa; Herbert Herzog; Susan D Brain
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

5.  The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.

Authors:  Niall P Hyland; Helen M Cox
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

6.  Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses.

Authors:  Helen M Cox; Iain R Tough; Anne-Marie Woolston; Lei Zhang; Amy D Nguyen; Amanda Sainsbury; Herbert Herzog
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

7.  Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.

Authors:  Lixin Wang; Guillaume Gourcerol; Pu-Qing Yuan; S Vincent Wu; Mulugeta Million; Muriel Larauche; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

8.  Agonism of free fatty acid receptors 1 and 4 generates peptide YY-mediated inhibitory responses in mouse colon.

Authors:  Runisha Moodaley; David M Smith; Iain R Tough; Marcus Schindler; Helen M Cox
Journal:  Br J Pharmacol       Date:  2017-11-08       Impact factor: 8.739

9.  A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress.

Authors:  S Forbes; H Herzog; H M Cox
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

10.  Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y₁ and Y₂ receptors.

Authors:  I R Tough; S Forbes; R Tolhurst; M Ellis; H Herzog; J C Bornstein; H M Cox
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.